Weekly Meeting Archives - Johns Hopkins University Center for Tuberculosis Research

TRAC Seminar Series

Please join us for the weekly Tuberculosis Research Advancement Center (TRAC) Seminar Series from 12:00 – 1:00 PM ET in CRB-2, 1M.13 or via Zoom: https://jhjhm.zoom.us/j/92237457953 | Add to Calendar

Graham Mooney, PhD
Associate Professor of History of Medicine and Epidemiology
Johns Hopkins University

Graham Mooney, PhD is an associate professor at JHU in the Department of the History of Medicine (School of Medicine) and Department of Epidemiology (Bloomberg School of Public Health). He is interested in the history of public health, particularly the control and management of infectious diseases. His first book, Intrusive Interventions: Public Health, Domestic Space, and Infectious Disease Surveillance in England 1840-1914 was published in 2015. He is currently working on a history of public health in Baltimore since World War 2.

The September TRAC Seminar Series on “Tuberculosis: Historical, Social, and Ethical Considerations” is presented by the Administrative Core.

TRAC Seminar Series

Recommended resources and works cited:

Click here to view a list of recommended resources as well as citations from Dr. Merritt’s 9/21 presentation.

Articles discussed during Dr. Merritt’s presentation:

Taylor HA, Dowdy DW, Searle AR, Stennett AL, Dukhanin V, Zwerling AA, Merritt MW. Disadvantage and the Experience of Treatment for Multidrug-Resistant Tuberculosis (MDR-TB). SSM Qual Res Health. 2022 Dec;2:100042. doi: 10.1016/j.ssmqr.2022.100042. Epub 2022 Jan 28. PMID: 35252955; PMCID: PMC8896740.

Dowdy DW, Zwerling AA, Stennett A, Searle A, Dukhanin V, Taylor HA, Merritt MW. Measuring Stigma to Assess the Social Justice Implications of Health-Related Policy Decisions: Application to Novel Treatment Regimens for Multidrug-Resistant Tuberculosis. MDM Policy Pract. 2020 Apr 26;5(1):2381468320915239. doi: 10.1177/2381468320915239. PMID: 32440569; PMCID: PMC7227142.

Maria W. Merritt, PhD
Core Faculty, Berman Institute of Bioethics
Associate Professor, Department of International Health, Bloomberg School of Public Health
Johns Hopkins University

My doctoral education was in philosophy, with a post-doctoral fellowship in bioethics. I’m interested in issues of public health ethics in international health. My methods combine philosophical inquiry and (in collaboration with social scientists) qualitative research to understand and address ethical issues as informed by the perspectives of people experiencing them. My current research agenda focuses on ethical aspects of the search for climate solutions.

The September TRAC Seminar Series on “Tuberculosis: Historical, Social, and Ethical Considerations” is presented by the Administrative Core.

TRAC Seminar Series

Margo A. Peyton, MD
Resident Physician
Department of Neurology, Mass General Brigham

Margo A. Peyton is a resident of the Mass General Brigham Neurology Program. Prior to medical school at Johns Hopkins, she worked in film and television story development for DreamWorks Animation. Her essays and book reviews have appeared in JAMA, Intima, and the Boston Society of Neurology, Neurosurgery, and Psychiatry. Her research on Arnold R. Rich was completed as part of the Johns Hopkins School of Medicine Scholarly Concentration program.

The September TRAC Seminar Series on “Tuberculosis: Historical, Social, and Ethical Considerations” is presented by the Administrative Core.

TRAC Seminar Series

Olivia Kates, MD, MA
Assistant Professor of Medicine
Division of Infectious Disease, Johns Hopkins University

Dr. Kates is an  Assistant Professor of Medicine at Johns Hopkins in Transplant Infectious Diseases and a bioethicist with the Berman Institute of Bioethics at Johns Hopkins. She studies ethical challenges in infectious diseases and organ transplantation, including pre-transplant vaccination requirements, liver transplantation for people who consume alcohol, and xenotransplantation, and is currently working with a multi-disciplinary group to develop ethically informed guidelines for TB isolation.

The September TRAC Seminar Series is presented by the Administrative Core.

TRAC Seminar Series

Michelle A. Rudek, Pharm.D., Ph.D.
Professor of Oncology and Medicine
Director, SKCCC Analytical Pharmacology Shared Resource
Co-Director, Co-Director, Pharmacology and Pharmacometrics Core for TRAC

The May TRAC Seminar Series is presented by the Pharmacology and Pharmacometrics Core.

TRAC Seminar Series

Martina Kovarova, PhD
Associate Professor
Division of Infectious Diseases, School of Medicine
University of North Carolina at Chapel Hill

Dr. Martina Kovarova, Ph.D. is an Associate Professor in the Department of Medicine, Division of Infectious Diseases at the University of North Carolina, School of Medicine. She received her Ph.D. at the 1st Faculty of Medicine, Charles University, Prague, and post-doctoral training at the National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland.

The main interest of Dr. Kovarova’s research is focused on the development of long-acting formulations for treatment and prevention of HIV, TB, and other infectious diseases. This includes nanoparticles, nanosuspensions, and In Situ Forming Implants (ISFI) technology. In addition, Dr. Kovarova has expertise in a field of preclinical evaluation of new HIV treatment strategies using humanized mice.

The May TRAC Seminar Series is presented by the Pharmacology and Pharmacometrics Core.

TRAC Seminar Series

Rob Christiaan van Wijk, PhD
Department of Bioengineering and Therapeutic Sciences
University of California San Francisco

The May TRAC Seminar Series is presented by the Pharmacology and Pharmacometrics Core.

TRAC Visiting Faculty Seminar

The TRAC MIAMI Core is pleased to host Dr. Ong for a special Visiting Faculty Seminar during the TRAC Seminar Series.

Dr Catherine ONG PhD FAMS FRCP
Assistant Professor, Department of Medicine, Yong Loo Lin School of Medicine, NUS
Principal Investigator, Institute for Health Innovation & Technology (iHealthtech)
Principal Investigator and Primary Member, Infectious Diseases Translational Research Programme
Senior Consultant, Division of Infectious Diseases, National University Hospital
Visiting Consultant, Tuberculosis Control Unit

Dr Catherine W.M. ONG MBBS MRCP(UK) MMed (Int Med) PhD FAMS FRCP is an Assistant Professor with the Department of Medicine at the Yong Loo Lin School of Medicine, Principal Investigator in iHealthtech NUS, Senior Consultant with the Division of Infectious Diseases in the National University Hospital and Visiting Consultant at the Singapore Tuberculosis Control Unit with both research and clinical interests in Tuberculosis. She serves in international journal editorial boards; as Associate Editor of the leading European Respiratory Journal, and Deputy Editor of the flagship International Journal of Tuberculosis and Lung Diseases. Her other portfolios include: Secretary to the ESCMID Study Group for Mycobacterial Infections (ESGMYC) and Vice-President of the Society of Infectious Disease (Singapore) in service of national and international societies.

Catherine graduated in medicine from NUS and during Infectious Diseases specialist training completed a full-time PhD at Imperial College London funded by the National Medical Research Council (NMRC) on the competitive National Research Foundation – Ministry of Health Scholarship. Her laboratory focuses on Tuberculosis host-pathogen interactions and TB host-directed therapies in multi-national clinical trials. Her works are published in top journals such as the Lancet Infectious Diseases, ERJ and the Journal of Clinical Investigation. Work is funded by the NMRC, Institut-Merieux, National Centre for Infectious Diseases and NUS with grant income as sole-PI of over SGD $10 million. Her students and research staff have won multiple national/international-level awards.

On clinical aspects of TB, Catherine serves the Ministry of Health Singapore, and works with WHO Coordinating Centres and WHO itself. For her work in tuberculosis, she received multiple national and international accolades. They include a Presidential Award prize at the American Society for Leukocyte Biology 2011, Keystone Symposia Global Health Travel Award by Bill and Melinda Gates Foundation 2012, International Investigator Award by the Infectious Diseases Society of America 2013, NMRC Transition Award 2015, Institut Merieux-SIDS Young Investigator Award 2018 and NMRC Clinician Scientist Award 2018 with successful renewal in 2022.

TRAC Seminar Series

Janice K Louie, MD, MPH
Medical Director, San Francisco Department of Public Health Tuberculosis Prevention and Control Program
Assistant Clinical Professor in the University of California San Francisco Department of Medicine

Dr. Janice Louie is Medical Director of the San Francisco Department of Public Health Tuberculosis Prevention and Control Program, and Assistant Clinical Professor in the University of California San Francisco Department of Medicine where she performs Infectious Disease Consultation. Her primary focus is to ensure continued excellence in the clinical management of tuberculosis, provide mentorship and training to fellows, residents and other trainees, and advancing clinical practices in tuberculosis with a focus on the elderly.

The April TRAC Seminar Series is presented by the TRAC Clinical Core on “Updates from NAR (The Union – North American Region) Conference.”

TRAC Seminar Series

Nicholas Paton, MD, FRCP
Professor of Infectious Diseases, National University of Singapore
Professor of Infectious Diseases, London School of Hygiene and Tropical Medicine

Prof. Nicholas Paton trained in Medicine and Infectious Diseases in Cambridge, Sydney and London, and in Epidemiology at the London School of Hygiene and Tropical Medicine. From 1997 to 2005 he worked as Head of Department at the National HIV Referral Centre in Singapore and, in addition to clinical care responsibilities, developed a Centre for Research in HIV and Communicable Diseases. From 2006 to 2011 he worked at the UK MRC Clinical Trials Unit where he was the Chief Investigator of large HIV treatment trials such as PIVOT (a trial of a PI-monotherapy strategy done at 45 clinical sites in the UK); and EARNEST (testing options for second-line therapy in over 1200 patients in 5 countries in sub-Saharan Africa).

He currently holds a joint appointment as Professor of Infectious Diseases at the National University of Singapore and at the London School of Hygiene and Tropical Medicine. He is the Chief Investigator of the NADIA trial (comparing dolutegravir with darunavir and comparing maintenance of tenofovir versus switching to zidovudine in second-line therapy, done in 7 sites in Uganda, Kenya and Zimbabwe) and the scientific lead of the CARES trial (comparing long acting cabotegravir/rilpivirine with standard combination ART at 8 sites in Uganda, Kenya and South Africa). In Singapore he leads a programme of TB trials focused on trials of host-directed therapies for TB and exploring novel TB trial outcome measures; and is the Chief Investigator on the TRUNCATE-TB trial (a strategy trial of 2 months of treatment for drug-susceptible TB done across a network of 18 sites in Asia and Africa).

The April TRAC Seminar Series is presented by the TRAC Clinical Core on “Updates from NAR (The Union – North American Region) Conference.”

Event

Event Category: Weekly Meeting

TRAC Seminar Series

TRAC Seminar Series

Recommended resources and works cited:

Articles discussed during Dr. Merritt’s presentation:

TRAC Seminar Series

TRAC Seminar Series

TRAC Seminar Series

TRAC Seminar Series

TRAC Seminar Series

TRAC Visiting Faculty Seminar

TRAC Seminar Series

TRAC Seminar Series